Literature DB >> 12083825

Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta.

Vasundhara Varthakavi1, Rita M Smith, Hongyu Deng, Ren Sun, Paul Spearman.   

Abstract

Human immunodeficiency virus type-1 (HIV-1) infection dramatically increases the risk of development of Kaposi's sarcoma (KS) in individuals infected with Kaposi's sarcoma-associated herpesvirus (KSHV). In a primary effusion lymphoma (PEL) tissue culture model system, HIV-1 replication potently induced the lytic replication of KSHV and led to the secretion of soluble factors capable of inducing lytic KSHV replication in bystander cells. Here we demonstrate that HIV induces KSHV lytic replication through activation of the KSHV Rta. HIV gene expression activated the KSHV Rta promoter following viral infection or after transfection of proviral DNA. Although HIV-1 Tat has previously been implicated as an activator of KSHV lytic replication, Tat alone was unable to activate lytic replication and failed to activate the Rta promoter. We conclude that HIV activates KSHV lytic replication by inducing the KSHV Rta promoter and that factors other than HIV-1 Tat are required to mediate this effect.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12083825     DOI: 10.1006/viro.2002.1434

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  25 in total

1.  Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1.

Authors:  Ossie F Dyson; Christopher M Traylen; Shaw M Akula
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

2.  Pregnancy and human herpesvirus 8 reactivation in human immunodeficiency virus type 1-infected women.

Authors:  Andrea Lisco; Massimo Barbierato; Josè R Fiore; Paola Gasperini; Anna Favia; Anna Volpe; Maria Chironna; Giuseppe Pastore; Luigi Chieco-Bianchi; Maria Luisa Calabrò
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

3.  The human cytomegalovirus UL112-113 locus can activate the full Kaposi's sarcoma-associated herpesvirus lytic replication cycle.

Authors:  Richard Wells; Laurence Stensland; Jeffrey Vieira
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

4.  Kaposi's sarcoma-associated herpesvirus virion-induced transcription activation of the ORF50 immediate-early promoter.

Authors:  Fang Lu; Latasha Day; Paul M Lieberman
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 5.  KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.

Authors:  Don Ganem
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

6.  Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Chun Lu; Yi Zeng; Zan Huang; Li Huang; Chao Qian; Guixia Tang; Di Qin
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

7.  Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.

Authors:  Yi Zeng; Xunhai Zhang; Zan Huang; Lin Cheng; Shuihong Yao; Di Qin; Xiuying Chen; Qiao Tang; Zhigang Lv; Ling Zhang; Chun Lu
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

8.  Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency.

Authors:  Fang Lu; Jing Zhou; Andreas Wiedmer; Kevin Madden; Yan Yuan; Paul M Lieberman
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Characterization of entry mechanisms of human herpesvirus 8 by using an Rta-dependent reporter cell line.

Authors:  Naoki Inoue; Jörn Winter; Renu B Lal; Margaret K Offermann; Shin Koyano
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Association of NFκB and related-cytokines with the viral load and development of antibodies against HHV-8 in people living with HIV/AIDS.

Authors:  Juliana Prado Gonçales; Thaísa Regina Rocha Lopes; Virginia Maria Barros de Lorena; Melayne Rocha Aciole; José Valter Joaquim Silva Júnior; Tania Regina Tozetto-Mendoza; Paulo Henrique Braz-Silva; Maria Rosangela Cunha Duarte Coêlho
Journal:  Med Microbiol Immunol       Date:  2019-10-04       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.